TP53 and cancer: TP53 mutations occurred in 12.5% (1 of 8 pairs), SUZ12 mutations in 62.5% (5 of 8 pairs), and the other 25% (2 of 8 pairs) had mutations in other cancer-related pathways, such as DNA repair genes.